This website covers the details of the IVC Filter litigation, including the connection to embolisms, bleeding, recalls, settlements and providing you legal help.
Why Are IVC Filter Lawsuits Being Filed
The claims involving the IVC Filter state the manufacturers of the device failed to warn patients and physicians of the increased risks of the filter breaking, and metal fragments moving through the blood, potentially damaging an organ.
Attorneys argue that C.R. Bard (the manufacturer) hid the results of its own research which had found the filter dangerous, and even forged an employee's signature on an FDA application in order to get approval.
Five products are most often involved in the IVC filter litigation: The Bard Recovery filter; The Bard G2 filter; The Bard G2 Express filter; The Cook Gunther Tulip filter; and the Cook Celect filter. Other filters causing problems include the Bard Eclipse, Bard Merdian, and Bard Denali.
What is the Purpose of an IVC Filter
The inferior vena cava (IVC) is a major vein that carries blood from the lower body into the heart. An IVC filter is a spider-like wire inserted into this vein in patients who are at high risk of a pulmonary embolism (a blockage in one of the arteries in the lungs).
The IVC filter's purpose is to prevent blood clots from entering the heart, lungs, kidneys or brain by catching the clots in the bloodstream and allowing them to break down over time. The filters often are used with patients who are not able to take anticoagulant medication (drugs that help prevent blood clots).
It's recommended that the filter be removed from the patient within six to twelve weeks of being inserted. The longer the filter remains in the patient the more difficult it is to remove, and the greater chance of injury.
A study conducted at Boston University School of Medicine found that IVC filters provide no significant benefit in survivability rate among trauma patients.
A separate clinical trial found that treating an acute pulmonary embolism patient with an IVC filter and an anticoagulation drug provided no additional benefit compared to treating the patient with just an anticoagulation drug.
IVC Filter Injuries & Side Effects
There have been reports of the IVC blood clot filter falling out of place or breaking apart. The metal device, or pieces from it, can then move through the blood, working their way through a vein wall and puncturing an internal organ.
There are also reports of blood clots occurring at the location where the device was inserted – the same clotting the device is supposed to prevent.
Below are some of the more frequent injuries experienced when IVC filters parts reach the heart or lungs.
|COMMON INJURIES||SEVERE INJURIES|
|Confusion||Hemorrhage (severe bleeding)|
|Heart Rhythm Problems||Pulmonary Embolism|
|Shortness of Breath|
|Hemorrhaging or Internal Bleeding|
What has happened in many cases is that an IVC filter fractures and sends small, sharp metal shards through the patient's circulatory system, or falls out of position altogether. Either way, this can cause severe, painful and life-threatening injuries.
When the artery is punctured, it can cause secondary injuries to other organs. The metal shards can even reach the heart itself, causing arrhythmia (irregular heartbeat), perforating the walls of the heart chamber.
It can also result in a condition known as cardiac tamponade, in which fluid such as pus or blood leaks into the pericardium (the tissue lining surrounding the heart muscle), causing pressure and interfering with heartbeat.
IVC Filter Lawsuit Videos
IVC Filter Lawsuit News
A company that made a blood-clot filter associated with 27 deaths and hundreds of problems replaced the device with a modified version that it knew had similar and potentially fatal flaws soon after it was put on the market. Confidential company records obtained by NBC News show that New Jersey-based medical device giant C.R. Bard was concerned about reports of failures for its G2 series filters, designed to replace the company's Recovery filter, within four months of being cleared to sell the G2 by the Food and Drug Administration. But instead of recalling the G2 filter, and the virtually identical G2 Express, the medical device manufacturer decided to keep them on the market for five years, until 2010, selling more than 160,000 of them. At least 12 deaths and hundreds of problems are now linked to the G2 series filters, according to Bard and FDA records. To read more, click NBC News - Blood-ClotDid Forged Signature Clear Way for Dangerous Blood-Clot Filter?
In 2002, medical giant C.R. Bard recruited Kay Fuller, a veteran regulatory specialist, to help secure FDA clearance for its Recovery blood clot filter, after the agency had turned down a previous application. The Recovery, a one-and-a-half-inch metal trap, was designed to sit inside a major vein, the vena cava, and block blood clots from traveling to the heart or lungs, where they could be deadly. To read more, click NBC News - Forged Signature
Serious questions are being raised about a medical device implanted in thousands of Americans at risk for blood clots — including whether the manufacturer told all it knew about potentially fatal flaws. At least 27 deaths have been associated with the Recovery filter — a spider-shaped apparatus that is inserted into the largest vein in the body — over the course of a decade, an NBC News investigation has found. To read more, click NBC News - Fatal Flaw
CR Bard Targeted in NBC News Investig. Over Blood Clot Filter: Purposely Hid Known Dangers
Earlier this month, NBC News completed a year-long investigation of medical device manufacturer CR Bard. It is the company responsible for the Recovery IVC filter, a device inserted into a major vein in order to prevent blood clots from reaching the lungs. Designed to be “retrievable” once the patient is no longer in danger from blood clots, this device has been implicated in 30 fatalities and 300 injuries. NBC News found evidence that Bard executives were fully aware of the dangers to patients who had the device implanted as far back as 2004. To read more, click Ring of Fire
For additional news stories, click Levin Law IVC Filter News
FDA and Scientific Studies Regarding IVC Filter
Removing Retrievable Inferior Vena Cava Filters: FDA Safety CommunicationThe FDA developed a quantitative decision analysis using publicly available data available in the medical literature to assess whether there is a time period during which the risk of having an IVC filter in place is expected to outweigh the benefits. The decision analysis (Decision Analysis of Retrievable Inferior Vena Cava Filters in Patients without Pulmonary Embolism) was published in the Journal of Vascular Surgery: Venous and Lymphatic Disorders in October 2013. The mathematical model suggested that if the patient’s transient risk for pulmonary embolism has passed, the risk/benefit profile begins to favor removal of the IVC filter between 29 and 54 days after implantation. To read more, click FDA Safety Alert
Perforation of the IVC: rule rather than exception after longer indwelling times for the Günther Tulip and Celect retrievable filtersPerforation of at least one filter component through the IVC was observed in 43 of 50 (86%) filters on CT scans obtained between 1 and 880 days after filter placement. All filters imaged after 71 days showed some degree of vena caval perforation, often as a progressive process. Filter tilt was seen in 20 of 50 (40%) filters, and all tilted filters also demonstrated vena caval perforation. Transjugular removal was attempted in 12 of 50 (24%) filters and was successful in 11 of 12 (92%). To read more, click Cardiovasc Intervent Radiology
Bard Recovery filter: evaluation and management of vena cava limb perforation, fracture, and migrationRecovery filter limb perforation of the vena cava increases over time and is associated with a 21% incidence of filter arm fracture and migration. Follow-up imaging is recommended. To read more, click Journal of Vascular and Interventional Radiology
Prevalence of Fracture and Fragment Embolization of Bard Retrievable Vena Cava Filters and Clinical Implications Including Cardiac Perforation and TamponadeThe Bard Recovery and Bard G2 filters had high prevalences of fracture and embolization, with potentially life-threatening sequelae. To read more, click JAMA Internal Medicine - Bard Filter
Frequent Fracture of TrapEase Inferior Vena Cava FiltersThe devices were evaluated at an average of 50.0 months after implantation. Among the 20 patients (20 TrapEase IVCFs), 10 TrapEase IVCFs (50%) were fractured. Remarkably, 9 of the 14 filters (64%) that had been inserted for longer than 4 years revealed fractures. Straight struts were fractured in all cases. Among the 10 fractured IVCFs, 8 had a single fractured strut, while 2 had multiple fractured struts. Radiographic and 3-D CT images revealed the geometrical relationships between the fracture sites and the neighboring structures. Among the fractured filters, the straight struts of the TrapEase IVCF seemed to be fractured by the compression of the vertebral bodies, particularly the vertebral osteophytes (9 cases) and the compression of the tortuous aorta (3 cases). To read more, click JAMA Internal Medicine - Vena Cava Filters
Inferior Vena Cava Filter Placement Does Not Result in a Survival Benefit for Trauma PatientsUsing IVC filters in a prophylactic manner has no benefit in trauma patient survivability, and in fact is linked with an increase in deep venous thrombosis. To read more, click Annals of Surgery
IVC Filter Recall Information
As of this time, there has not been a recall of Bard's IVC blood clot filter. However, the FDA has issued two warnings about the device, and recommends that it be used only temporarily if a patient is unable to take anticoagulant (blood clot) medication.
The FDA recommends that patients who have received an IVC Filter talk with their physicians as soon as possible to make sure it has not moved or broken apart, and whether the device should now be removed.
IVC Filter Settlement Information
As of this time, there have been no large group settlements involving the IVC filters. Litigation likes this takes many years to resolve, with teams of lawyers spending millions of dollars trying to determine exactly what occurred, and how it could have been prevented. Generally, large groups of settlements do not occur until such time as a few cases are tried before a jury, and the manufacturer is able to more thoroughly understand its financial risk.